Combination Therapies of DPP4 Inhibitors and GLP1 Analogues with Insulin in Type 2 Diabetic Patients: A Systematic Review

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|11|6|992-1000

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.11, Iss.6, 2013-11, pp. : 992-1000

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging Incretin-Based Therapies for Type 2 Diabetes: Incretin Mimetics and DPP-4 Inhibitors

By  

Current Diabetes Reviews, Vol. 4, Iss. 2, 2008-05 ,pp. : 101-109

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of GLP-1 treatment on GLUT2 and GLUT4 expression in type 1 and type 2 rat diabetic models

By Villanueva-Peñacarrillo María   Puente Jesús   Redondo Araceli   Clemente Felipe   Valverde Isabel  

Endocrine Journal, Vol. 15, Iss. 2, 2001-07 ,pp. : 241-248

Humana Press, Inc

Access to resources Recommend Favorite

Treatment of Type 1 Diabetic Patients with Glucagon-Like Peptide-1 (GLP-1) and GLP-1R Agonists

By  

Current Diabetes Reviews, Vol. 5, Iss. 4, 2009-11 ,pp. : 266-275

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of GLP-1 Based Therapies on Diabetic Dyslipidemia

By  

Current Diabetes Reviews, Vol. 10, Iss. 4, 2014-07 ,pp. : 238-250

Bentham Science Publishers

Access to resources Recommend Favorite

Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes

By Højberg P.   Zander M.   Vilsbøll T.   Knop F.   Krarup T.   Vølund A.   Holst J.   Madsbad S.  

Diabetologia, Vol. 51, Iss. 4, 2008-04 ,pp. : 632-640

Springer Publishing Company

Access to resources Recommend Favorite